| Prasad Lakshminarasimhiah, MD | |
|
5575 Warren Pkwy, Ste 104, Frisco, TX 75034-4062 | |
| (817) 576-0896 | |
| (972) 294-5148 |
| Full Name | Prasad Lakshminarasimhiah |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 24 Years |
| Location | 5575 Warren Pkwy, Frisco, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366606311 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 37912 (Iowa) | Secondary |
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | N9463 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Pain Relief Group Pllc | 2668603952 | 23 |
News Archive
The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Researchers are edging ever closer to discovering the perfect combination of drugs and drug delivery system that will stop the sexual transmission of HIV.
When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question.
› Verified 8 days ago
| Entity Name | Texas Pain Relief Group Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003246299 PECOS PAC ID: 2668603952 Enrollment ID: O20140331000940 |
News Archive
The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Researchers are edging ever closer to discovering the perfect combination of drugs and drug delivery system that will stop the sexual transmission of HIV.
When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Prasad Lakshminarasimhiah, MD 4730 N Habana Ave, Ste 204, Tampa, FL 33614-7163 Ph: (813) 549-2134 | Prasad Lakshminarasimhiah, MD 5575 Warren Pkwy, Ste 104, Frisco, TX 75034-4062 Ph: (817) 576-0896 |
News Archive
The U.S. Food and Drug Administration today approved Mepsevii (vestronidase alfa-vjbk) to treat pediatric and adult patients with an inherited metabolic condition called mucopolysaccharidosis type VII (MPS VII), also known as Sly syndrome. MPS VII is an extremely rare, progressive condition that affects most tissues and organs.
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals International GmbH, today announced that the European Commission has granted Marketing Authorisation for Entyvio (vedolizumab), a gut-selective humanized monoclonal antibody, and the first and only biologic therapy to be approved simultaneously for the treatment of adults with moderately to severely active ulcerative colitis (UC) and adults with moderately to severely active Crohn's disease (CD) who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumor necrosis factor-alpha (TNFα) antagonist.
Researchers are edging ever closer to discovering the perfect combination of drugs and drug delivery system that will stop the sexual transmission of HIV.
When 91-year-old Irvin Lafferty was diagnosed with severe blockage of his heart valve-hardening that is formally known as aortic valve stenosis-open-heart surgery was out of the question.
› Verified 8 days ago
Johanna Elizabeth Hogan, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 16061 Coit Rd, Frisco, TX 75035 Phone: 469-219-2300 | |
Jessica Dabis, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5700 Dallas Pkwy, Frisco, TX 75034 Phone: 469-515-7158 | |
Dr. David C. Lo, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 2990 Legacy Dr, Frisco, TX 75034 Phone: 469-888-5100 Fax: 469-888-5222 | |
Dr. Laura C. Schick, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2895 Bandolier Ln, Frisco, TX 75034 Phone: 972-841-6628 | |
Fernando Rios Trevino, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5700 Dallas Pkwy, Frisco, TX 75034 Phone: 469-515-7222 | |
Anna V Chavez, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2990 Legacy Dr, Frisco, TX 75034 Phone: 469-888-5200 | |
Benjamin R. Selbo, D. P.T. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 5000 Eldorado Pkwy Ste 430, Frisco, TX 75033 Phone: 214-436-4606 Fax: 214-436-4794 |